NCT05223608View on ClinicalTrials.gov

Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

March 3, 2022

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2028

Conditions
Solid Tumor, Adult
Interventions
OTHER

ImmuCCo Cohort

Blood sampling at initiation of immunotherapy, at the first tumor assessment, in case of severe toxicity. Urine collection at initiation of immunotherapy.

Trial Locations (1)

59

RECRUITING

Centre Oscar Lambret, Lille

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Centre Oscar Lambret

OTHER